Varnimcabtagene Autoleucel (ARI-0001) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Richter Transformation (RT)

被引:1
|
作者
Ortiz-Maldonado, Valentin [1 ]
Martinez-Cibrian, Nuria [2 ]
Del Campo Balguerias, Gonzalo [3 ]
Espanol-Rego, Marta [4 ]
Navarro, Sergio [4 ]
Lopez-Oreja, Irene [5 ]
Nadeu, Ferran [6 ]
Cobo, Amparo [7 ]
Brillembourg, Helena [8 ]
Alserawan, Leticia [9 ]
Castella, Maria [9 ]
Benitez-Ribas, Daniel [9 ]
Magnano, Laura [8 ]
Gonzalo Correa, Juan [10 ]
Rivero, Andrea [10 ]
Mozas, Pablo [8 ]
Gine, Eva [11 ]
Gerardo Rodriguez-Lobato, Luis [10 ]
Martinez-Roca, Alexandra [12 ]
Montoro-Lorite, Mercedes [8 ]
Ayora, Pilar [8 ]
Fernandez de Larrea, Carlos [10 ]
Pascal, Mariona [9 ]
Setoain, Xavier [7 ]
Esteve Reyner, Jordi [8 ]
Urbano-Ispizua, Alvaro [8 ]
Juan, Manel [13 ]
Delgado, Julio [2 ]
机构
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Hosp Clin Barcelona, Barcelona, Spain
[3] Hosp Clinico San Carlos, Dept Hematol, Madrid, Spain
[4] Hosp Clin Barcelona, Dept Immunol, Barcelona, Spain
[5] Hosp Clin Barcelona, IDIBAPS, Hematopathol Sect, Barcelona, Spain
[6] IDIBAPS, Barcelona, Spain
[7] Hosp Clin Barcelona, Nucl Med Unit, Barcelona, Spain
[8] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain
[9] Hosp Clin Barcelona, Dept Immunol, Barcelona, Spain
[10] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain
[11] Univ Barcelona, Hosp Clin Barcelona, IDIBAPS, Barcelona, Spain
[12] Hosp Clin Barcelona, ICMHO, Hematol Dept, Barcelona, Spain
[13] Hosp Clin Barcelona, Sant Joan Deu, Immunotherapy Clin, Dept Immunol, Barcelona, Spain
关键词
D O I
10.1182/blood-2023-182896
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Isolated Richter's transformation in central nervous system in a patient with refractory chronic lymphocytic leukemia
    Cetintepe, Tugba
    Kobak, Fusun Gediz
    Bener, Sadi
    INDIAN JOURNAL OF CANCER, 2021, 58 (03) : 428 - 430
  • [42] Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia
    McCune, SL
    Gockerman, JP
    Moore, JO
    Decastro, CM
    Bass, AJ
    Chao, NJ
    Long, GD
    Vredenburgh, JJ
    Gasparetto, C
    Adams, D
    Payne, N
    Rizzieri, DA
    LEUKEMIA & LYMPHOMA, 2002, 43 (05) : 1007 - 1011
  • [43] Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
    Brown, J. R.
    Eichhorst, B.
    Hillmen, P.
    Jurczak, W.
    Kazmierczak, M.
    Lamanna, N.
    O'Brien, S. M.
    Tam, C. S.
    Qiu, L.
    Zhou, K.
    Simkovic, M.
    Mayer, J.
    Gillespie-Twardy, A.
    Ferrajoli, A.
    Ganly, P. S.
    Weinkove, R.
    Grosicki, S.
    Mital, A.
    Robak, T.
    Osterborg, A.
    Yimer, H. A.
    Salmi, T.
    Wang, M. -D. -Y.
    Fu, L.
    Li, J.
    Wu, K.
    Cohen, A.
    Shadman, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (04): : 319 - 332
  • [44] Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
    Shustik, C.
    Bence-Bruckler, I.
    Delage, R.
    Owen, C. J.
    Toze, C. L.
    Coutre, S.
    ANNALS OF HEMATOLOGY, 2017, 96 (07) : 1185 - 1196
  • [45] Economic burden of relapsed/refractory chronic lymphocytic leukemia
    Guerin, Annie
    Ray, Saurabh
    Gauthier, Genevieve
    Hsu, Ling-I
    Zhdanava, Maryia
    Heroux, Julie
    Wu, Eric
    LEUKEMIA & LYMPHOMA, 2015, 56 : 40 - 41
  • [46] Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Florian Simon
    Jan-Paul Bohn
    Current Oncology Reports, 2023, 25 : 1181 - 1189
  • [47] Pharmacokinetic, safety and efficacy of high dose simvastatin in refractory and relapsed chronic lymphocytic leukemia (CLL) patients
    Ahmed, Tamer
    Hayslip, John
    Leggas, Markos
    CANCER RESEARCH, 2012, 72
  • [48] A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL)
    Nabhan, C
    Patton, D
    Gordon, LI
    Riley, MB
    Kuzel, T
    Tallman, MS
    Rosen, ST
    LEUKEMIA & LYMPHOMA, 2004, 45 (11) : 2269 - 2273
  • [49] Characterization and predictors of sleep disturbance in patients with relapsed/refractory chronic lymphocytic leukemia (r/r CLL)
    Westbrook, Travis D.
    Maddocks, Kami J.
    Andersen, Barbara L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study
    Van Den Neste, Eric
    Cazin, Bruno
    Janssens, Ann
    Gonzalez-Barca, Eva
    Jose Terol, Maria
    Levy, Vincent
    Perez de Oteyza, Jaime
    Zachee, Pierre
    Saunders, Andrew
    de Frias, Merce
    Campas, Clara
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 581 - 591